SCHEMBL29595462

SCHEMBL29595462

Fc1cccc(C(F)(F)F)c1Br

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAS2R14 Q9NYV8 1/20 0.41
HSD11B1 P28845 2/20 0.38
P2RX7 Q99572 1/20 0.37
SLC22A12 Q96S37 1/20 0.37
LMNA P02545 1/20 0.35
GAA P10253 1/20 0.35
TRPA1 O75762 1/20 0.35
ALDH1A1 P00352 1/20 0.34
POLB P06746 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
AXL P30530 1/20 0.34
KIF11 P52732 1/20 0.34
PTGS2 P35354 1/20 0.34
CYP11B1 P15538 1/20 0.33
CYP11B2 P19099 1/20 0.33
CES1 P23141 1/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
MPL P40238 1/20 0.33
HDAC3 O15379 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1198277 1.00 TAS2R14 (0.41) TAS2R14HSD11B1P2RX7SLC22A12LMNA
SCHEMBL28463878 0.86 CA1 (0.31) TAS2R14HSD11B1SLC22A12CES1CA2
SCHEMBL1041748 0.85 TAS2R14 (0.46) TAS2R14HSD11B1P2RX7LMNAGAA
SCHEMBL10873924 0.83 CES2 (0.32) CES1
SCHEMBL16127258 0.81 HSD11B1 (0.40) TAS2R14HSD11B1P2RX7SLC22A12TRPA1
SCHEMBL7191759 0.78 TAS2R14 (0.42) TAS2R14HSD11B1P2RX7LMNAGAA
SCHEMBL28918935 0.76 P2RX7 (0.41) TAS2R14HSD11B1P2RX7LMNAGAA
SCHEMBL610147 0.76
SCHEMBL24270237 0.76 CA2 (0.37) HSD11B1ALDH1A1TDP1CYP11B1CYP11B2
SCHEMBL7768199 0.76 CA2 (0.32) CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4587014-A2 C5AR1 ANTAGONISTS AND USES THEREOF Vanqua Bio, Inc. (US) 2025-07-23 EP disclosed
WO-2024243025-A1 NAPHTHYL-SUBSTITUTED PYRIDO[4,3-D]PYRIMIDINES AND RELATED COMPOUNDS AND THEIR USE IN TREATING MEDICAL CONDITIONS Ikena Oncology, Inc. (US) 2024-11-28 WO disclosed
WO-2024059096-A2 C5AR1 ANTAGONISTS AND USES THEREOF VANQUA BIO, INC. (US) 2024-03-21 WO disclosed
CN-110678177-B Pyrazole MAGL inhibitors H.隆德贝克有限公司 2023-06-13 CN disclosed